Hematological Manifestations among Patients with Rheumatic Diseases
- PMID: 33221805
- DOI: 10.1159/000511759
Hematological Manifestations among Patients with Rheumatic Diseases
Abstract
Background: Rheumatic diseases have many hematological manifestations. Blood dyscrasias and other hematological abnormalities are sometimes the first sign of rheumatic disease. In addition, novel antirheumatic biological agents may cause cytopenias.
Summary: The aim of this review was to discuss cytopenias caused by systemic lupus erythematosus and antirheumatic drugs, Felty's syndrome in rheumatoid arthritis, and autoimmune hemolytic anemia, thrombosis, and thrombotic microangiopathies related to rheumatological conditions such as catastrophic antiphospholipid syndrome and scleroderma renal crisis. Key Message: The differential diagnosis of various hematological disorders should include rheumatic autoimmune diseases among other causes of blood cell and hemostasis abnormalities. It is crucial that hematologists be aware of these presentations so that they are diagnosed and treated in a timely manner.
Keywords: Anemia; Antiphospholipid syndrome; Arthritis; Leukopenia; Rheumatic diseases; Systemic lupus erythematosus; Thrombocytopenia; Thrombosis; Thrombotic microangiopathy; Vasculitis.
© 2020 S. Karger AG, Basel.
Similar articles
-
Use of colony-stimulating factors in the treatment of neutropenia associated with collagen vascular disease.Curr Opin Hematol. 1997 May;4(3):196-9. doi: 10.1097/00062752-199704030-00007. Curr Opin Hematol. 1997. PMID: 9209836 Review.
-
Zytopenien : Anämie, Leukopenie und Thrombopenie.Z Rheumatol. 2017 Oct;76(Suppl 2):63-74. doi: 10.1007/s00393-017-0364-7. Z Rheumatol. 2017. PMID: 28971213 Review. German.
-
Thrombotic Microangiopathies with Rheumatologic Involvement.Rheum Dis Clin North Am. 2018 Nov;44(4):635-649. doi: 10.1016/j.rdc.2018.06.010. Epub 2018 Sep 7. Rheum Dis Clin North Am. 2018. PMID: 30274628 Review.
-
[Rheumatic and hemato-/oncological disorders].Z Rheumatol. 2005 Feb;64(1):3-11. doi: 10.1007/s00393-005-0698-4. Z Rheumatol. 2005. PMID: 15756494 Review. German.
-
Coexistent Felty's syndrome and palindromic rheumatism.Ann Rheum Dis. 1991 Dec;50(12):953-5. doi: 10.1136/ard.50.12.953. Ann Rheum Dis. 1991. PMID: 1768169 Free PMC article.
Cited by
-
Immune Checkpoint Inhibitor-Related Cytopenias: About 68 Cases from the French Pharmacovigilance Database.Cancers (Basel). 2022 Oct 14;14(20):5030. doi: 10.3390/cancers14205030. Cancers (Basel). 2022. PMID: 36291814 Free PMC article.
-
A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19.Adv Ther. 2022 Nov;39(11):4910-4960. doi: 10.1007/s12325-022-02281-4. Epub 2022 Sep 5. Adv Ther. 2022. PMID: 36063279 Free PMC article. Review.
-
Autoimmune hemolytic anemia as an initial presentation in children with systemic lupus erythematosus: two case reports.J Int Med Res. 2022 Aug;50(8):3000605221115390. doi: 10.1177/03000605221115390. J Int Med Res. 2022. PMID: 35971316 Free PMC article. Review.
-
A Case of Rheumatoid Arthritis Complicated by Compression of the Popliteal Artery and Tibial Nerve Due to an Organized Hematoma in the Popliteal Fossa: A Case Report and Literature Review.Diagnostics (Basel). 2025 May 16;15(10):1265. doi: 10.3390/diagnostics15101265. Diagnostics (Basel). 2025. PMID: 40428258 Free PMC article.
-
Safety profile of baricitinib in patients with systemic lupus erythematosus: an integrated analysis.RMD Open. 2023 Aug;9(3):e003302. doi: 10.1136/rmdopen-2023-003302. RMD Open. 2023. PMID: 37604638 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical